Complement and Immunoregulation in Tissue Injury
Abstract
Our goal is to ultimately enable the development of novel therapeutic agents and strategies to ameliorate tissue injury in I/R related conditions. Preliminary findings suggested a role for Il-17 & IL-23 axis in ischemia reperfusion injury which we have continued to study. We have shown that by depleting IL-17 and IL-23 tissue injury is alleviated.
Document Details
- Document Type
- Technical Report
- Publication Date
- Oct 01, 2014
- Accession Number
- ADA624271
Entities
People
- George Tsokos
Organizations
- Beth Israel Deaconess Medical Center